130 related articles for article (PubMed ID: 7779912)
21. L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential.
Stockschlaeder MA; Storb R; Osborne WR; Miller AD
Hum Gene Ther; 1991; 2(1):33-9. PubMed ID: 1650586
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid-induced differentiation of retrovirus-infected HL-60 cells is associated with enhanced transcription from the viral long terminal repeat.
Collins SJ
J Virol; 1988 Nov; 62(11):4349-52. PubMed ID: 3172345
[TBL] [Abstract][Full Text] [Related]
23. Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences.
Kirschmeier PT; Housey GM; Johnson MD; Perkins AS; Weinstein IB
DNA; 1988 Apr; 7(3):219-25. PubMed ID: 2836147
[TBL] [Abstract][Full Text] [Related]
24. Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression.
Dai HY; Etzerodt M; Baekgaard AJ; Lovmand S; Jørgensen P; Kjeldgaard NO; Pedersen FS
Virology; 1990 Apr; 175(2):581-5. PubMed ID: 2158188
[TBL] [Abstract][Full Text] [Related]
25. Mammalian expression-and-transmission vector derived from Akv murine leukemia virus.
Jensen NA; Jørgensen P; Kjeldgaard NO; Pedersen FS
Gene; 1986; 41(1):59-65. PubMed ID: 3009276
[TBL] [Abstract][Full Text] [Related]
26. Retrovirus vector-targeted inducible expression of human beta-interferon gene to B-cells.
Engelhardt JF; Kellum MJ; Bisat F; Pitha PM
Virology; 1990 Oct; 178(2):419-28. PubMed ID: 2171189
[TBL] [Abstract][Full Text] [Related]
27. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region.
Celander D; Haseltine WA
J Virol; 1987 Feb; 61(2):269-75. PubMed ID: 3027359
[TBL] [Abstract][Full Text] [Related]
29. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
30. Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene.
Paludan K; Duch M; Jørgensen P; Kjeldgaard NO; Pedersen FS
Gene; 1989 Dec; 85(2):421-6. PubMed ID: 2560757
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting the performance of different long terminal repeats in the retroviral vector.
Kim S; Lee K; Kim MD; Kang S; Joo CW; Kim JM; Kim SH; Yu SS; Kim S
Biochem Biophys Res Commun; 2006 May; 343(4):1017-22. PubMed ID: 16574062
[TBL] [Abstract][Full Text] [Related]
32. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
33. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
34. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.
Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K
Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
36. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
37. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.
Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974
[TBL] [Abstract][Full Text] [Related]
38. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
39. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells.
Marx JC; Allay JA; Persons DA; Nooner SA; Hargrove PW; Kelly PF; Vanin EF; Horwitz EM
Hum Gene Ther; 1999 May; 10(7):1163-73. PubMed ID: 10340548
[TBL] [Abstract][Full Text] [Related]
40. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
